A modified Kagan's amide, N -(( S )-1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-3,5-dinitrobenzamide has been designed, synthesized and screened as a Chiral Solvating Agent for discrimination of optically active substrates.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: